Australia, July 24 -- Vir Biotechnology Inc., owns the trademark (2545941) for 'ENCENTRIO' till March 20, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical and biological preparations and medicinal infusions for prevention and treatment of infectious diseases and disorders, viral diseases and disorders, and in the field of oncology.], 42 [Research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials, and post-market trials.] and 44 [Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders, and conditions; medical and pharmaceutical consultation.]
Type of Mark: Word
Date of Acceptance: May 16
Registration Advertised: July 23
For further details contact Davies Collison Cave Pty. Ltd. and P.C. Amanda B. Agati Fross Zelnick Lehrman & Zissu.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2545941.
Disclaimer: Curated by HT Syndication.
